
DiaMedica Therapeutics has received a No Objection Letter (NOL) from Health Canada, giving the company regulatory clearance to start its …
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches £20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations

